Hemant Surgical Industries last traded at ₹633.10 (2026-10-13). Over the past month the stock moved +36.2%, three months the stock moved +54.2%, year the stock moved +94.6%. Its closing range over 52 weeks is ₹242.95 – ₹665.20, with the latest close 4.8% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]
Business Overview:[1][2] HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc. b) Design and manufacture of a range of nebulisers, which are marketed under the company’s AERO brand c) HSIL also refurbishes second-hand dialysis machines, manufactures and supplies related accessories, dialysers and haemodialysis solutions
In the latest quarter (Mar 2026), Hemant Surgical Industries reported sales of ₹167.00 crore (+187.9%) and net profit of ₹13.00 crore (+116.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 167.00 | 16.00 | 9.00 | 13.00 | 9.84 |
| Sep 2025 | 64.00 | 8.00 | 12.00 | 5.00 | 4.15 |
| Mar 2025 | 58.00 | 6.00 | 10.00 | 5.00 | 4.74 |
| Sep 2024 | 49.00 | 4.00 | 7.00 | 3.00 | 3.05 |
| Mar 2024 | 58.00 | 7.00 | 13.00 | 6.00 | 5.63 |
| Sep 2023 | 48.00 | 3.00 | 7.00 | 4.00 | 3.75 |
| Mar 2023 | 58.00 | 6.00 | 11.00 | 5.00 | 6.93 |
| Sep 2022 | 51.00 | 4.00 | 8.00 | 2.00 | 48.12 |
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales growth | -3.9% | +0.0% | +33.3% | +187.9% |
| Operating profit growth | +0.0% | +0.0% | +166.7% | +128.6% |
| Net profit growth | +50.0% | +0.0% | +25.0% | +116.7% |
| EPS growth | -93.7% | -31.6% | +10.7% | +74.8% |
| OPM % | 7.0% | 10.0% | 12.0% | 9.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Hemant Surgical Industries reported sales of ₹231.00 crore (+115.9%) and net profit of ₹18.00 crore (+125.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 231.00 | 23.00 | 10.00 | 18.00 | 13.98 |
| Mar 2025 | 107.00 | 9.00 | 9.00 | 8.00 | 7.79 |
| Mar 2024 | 106.00 | 10.00 | 10.00 | 10.00 | 9.39 |
| Mar 2023 | 109.00 | 11.00 | 10.00 | 8.00 | 9.95 |
| Mar 2022 | 101.00 | 6.00 | 6.00 | 5.00 | 248.92 |
| Mar 2021 | 60.00 | 3.00 | 5.00 | 1.00 | 73.43 |
| Mar 2020 | 56.00 | 3.00 | 5.00 | 0.00 | 27.00 |
| Mar 2019 | 56.00 | 3.00 | 5.00 | 1.00 | 61.02 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +9.8% | +0.0% | +7.1% | +68.3% | +7.9% | -2.8% | +0.9% | +115.9% |
| Operating profit growth | +50.0% | +0.0% | +0.0% | +100.0% | +83.3% | -9.1% | -10.0% | +155.6% |
| Net profit growth | +0.0% | -100.0% | – | +400.0% | +60.0% | +25.0% | -20.0% | +125.0% |
| EPS growth | +20.2% | -55.8% | +172.0% | +239.0% | -96.0% | -5.6% | -17.0% | +79.5% |
| OPM % | 5.0% | 5.0% | 5.0% | 6.0% | 10.0% | 10.0% | 9.0% | 10.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Hemant Surgical Industries.
Get Free AI Stock Analysis FREE →No recent news available for Hemant Surgical Industries.
Hemant Surgical Industries shares were last quoted at ₹633.10 (-4.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Hemant Surgical Industries has a price-to-earnings (P/E) ratio of 39.87 and a price-to-book (P/B) ratio of 6.01. The industry P/E is 44.09.
The 52-week high of Hemant Surgical Industries is ₹629.75 and the 52-week low is ₹215.00.
The market capitalisation of Hemant Surgical Industries is about ₹765.16 crore.
In the latest quarter (Mar 2026), Hemant Surgical Industries reported sales of ₹167.00 crore (+187.9%) and net profit of ₹13.00 crore (+116.7%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Hemant Surgical Industries has a 3-year ROE of 18.00%, 3-year profit growth of 34.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 52.83% of Hemant Surgical Industries.
Hemant Surgical Industries belongs to the Medical Equipment/Supplies/Accessories sector.
All Medical Equipment/Supplies/Accessories stocks · Browse all stocks A–Z